Biochrom announces major appointment - Sam Luke as new Group Managing Director
Biochrom Ltd, the Cambridge based subsidiary of Harvard Bioscience Inc. (Nasdaq:HBIO), has announced the appointment of Sam Luke as its new Group Managing Director.
Commenting on his appointment Sam Luke said, “I am delighted to be back in Cambridge and joining a very talented team. This is an exciting time to join Biochrom. Following the recent launch of the new Biochrom Libra range of double beam UV spectrophotometers and new amino acid analyzers, we aim to focus on business growth, building on the momentum achieved to date.”
Sam holds an Engineering degree from Clare College, the University of Cambridge, UK, and has more than 25 years experience in the instrumentation and measurement market. He spent the last six years as the European General Manager for the customer services division of Agilent Technologies. Prior to that, he held a number of senior positions in sales and marketing at Agilent Technologies and Hewlett Packard.
HBIO Division President Jeff Cohen welcomed Sam saying; “His wealth of experience, leadership and strong customer focus will be invaluable as Biochrom pursues an active product development programme and expands operations worldwide.”
Sam takes the helm of a company with rapidly expanding future potential and a 40 year history of designing and manufacturing high quality scientific instrumentation for the Analytical and Life Science sectors behind it.
For more information visit: www.biochrom.co.uk
To read more information, click here.
Based on the Cambridge (UK) Science Park, Biochrom is a leading global manufacturer with more than 40 years of experience producing high quality scientific instrumentation. Trusted by customers in hospitals and laboratories worldwide, the company is also a valued OEM partner to many of the world’s finest scientific instrumentation companies.